EVENT PREVIEW

Outsourcing in Clinical Trials Europe 2022

4-5 May 2022
Hyatt Regency Barcelona Tower
Barcelona, Spain
arena-international.com

Clinical trials are enormously complex and expensive undertakings. A clinical trial is a portion of the entire drug development process, from inception of the drug compound to bringing the drug to market. Globally, it is estimated that over US$40billion is spent on clinical trials each year.

A pharmaceutical company can expect to have spent $350m to get one drug to market, based on research conducted with 98 companies over a decade. On average, approximately 33% of the trial budget will be spent on investigative site (hospitals/universities etc) costs (reimbursement to investigators and site owners). Internal costs (resources deployed by the pharmaceutical company) may account for approximately 25% of the budget. The remainder is usually accounted for by outsourced services (central labs 5%, CROs – various, as high as 62% of trial budget in some cases).

Arena International are delighted to announce Outsourcing in Clinical Trials Europe will be returning to Barcelona for our in-person event.

For the 12th Annual event, our flagship European clinical show will provide delegates with practical take-aways and solutions to their most current operational and outsourcing challenges in clinical trials. This is an event not to be missed!

The 2022 program boasts multiple streams across 2 days, jam packed with content. Day 1 will kick off with a low down on Decentralized and Hybrid Trials, looking at the best way to implement these in Europe, by the Head of LEO Innovation Lab. We will also hear a keynote on ‘The Diversity Conversation’, discussing underrepresentation in clinical trials and what we can do about it now.

The Technology track will see Kai Langel, Senior Director of Strategy and Innovation at Janssen, discuss digital therapeutics; as well as an interactive discussion on how to create a clinical landscape where small companies have better access to technology.

Opening Day 2 we have our expert panel debating how best to build trust with your CRO in a virtual landscape. The Speaking Faculty includes the likes of Janssen, Sanofi, Fresenius Medical Care,Alexion, AstraZeneca, Daiichi Sankyo, Roche, Medac and many more.

Go to article: Home | Two years of Covid-19Go to article: In this issueGo to article: ContentsGo to article: Mimotopes Company Insight Go to article: MimotopesGo to article: CSafe GlobalGo to article: BriefingGo to article: Industry newsGo to article: The pharma industry briefingGo to article: Covid-19 executive briefing by GlobalDataGo to article: Controlant Company InsightGo to article: ControlantGo to article: Contract Pharmaceuticals Limited CanadaGo to article: CommentGo to article: Ukraine: Russian invasion could cause spike in Covid-19 cases Go to article: First vaccines, now drugs: FDA’s second wave of emergency Covid-19 approvalsGo to article: International Women’s Day spotlight: endometriosisGo to article: Remote audits – stopgap measure or the new normal?Go to article: Owen Mumford Company Insight Go to article: Owen MumfordGo to article: BaxterGo to article: In DepthGo to article: Two years of Covid-19: lessons the pandemic taught about delivering essential vaccinesGo to article: A perfect storm: Covid-19 viral vector manufacturing adds further burden to CAR-Go to article: Russia sanctions: what next for Sputnik Covid-19 vaccine production around the wGo to article: Profit for patients: can NFTs allow people to monetise their health data?Go to article: Navigating distribution challenges for rare disease drugsGo to article: NiproGo to article: Datwyler Company InsightGo to article: DatwylerGo to article: In DataGo to article: North America is seeing a hiring boom in pharma digital media rolesGo to article: Filings buzz: 23% increase in industrial automation mentions in Q3 of 2021Go to article: Event: Outsourcing in Clinical Trials Europe 2022Go to article: EventsGo to article: Next issue